See also this year's filing and all EDGAR filings for this company.
PDF Report 0001445815_2026_Bioxytran_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001445815, Bioxytran INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 513,465 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 145,087 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 3,249,894 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 696,936 |
| 9 | ResearchAndDevelopmentExpense | 387,869 |
| 10 | remainder_Expenses | 757,204 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -285,188 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 658,552 |
| 1 | Liabilities | 3,249,894 |
| 2 | Expenses | 1,842,009 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -2,591,342 |
| 5 | NetIncome | -2,127,197 |
| 6 | ComprehensiveNetIncome | -2,127,197 |
| 7 | BaseVar | 3,017,822 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.98 |
| 9 | EconomicCapitalRatio | 0.397 |